Literature DB >> 17303786

Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients.

Cristiane B Leitão1, Luís H Canani, Caroline K Kramer, Juliana C Boza, Antônio F Pinotti, Jorge L Gross.   

Abstract

OBJECTIVE: To evaluate the impact of masked hypertension in normotensive type 2 diabetic patients on microvascular complications and echocardiographic parameters. RESEARCH DESIGN AND METHODS: A cross-sectional study was conducted in 135 normotensive patients with type 2 diabetes. Patients underwent urinary albumin excretion rate (UAER) measurement, echocardiography, and 24-h ambulatory blood pressure monitoring (ABPM). Patients with increased daytime blood pressure levels (> or = 135/85 mmHg) were classified as having masked hypertension.
RESULTS: The prevalence of masked hypertension was 30% (n = 41). Normotensive and masked hypertensive subjects, based on ambulatory blood pressure, were not different in terms of age, diabetes duration, smoking status, BMI, waist circumference, serum creatinine, glycemic, or lipid profiles. The office systolic blood pressure was higher in those with masked hypertension (127.8 +/- 7.5 vs. 122.9 +/- 10.2 mmHg, P = 0.003) than in the normotensive group. UAER also was increased in the group with masked hypertension (21.3 microg/min [range 2.5-1,223.5] vs. 8.1 microg/min [1.0-1,143.0], P = 0.001), as was the interventricular septum (1.01 +/- 0.15 vs. 0.94 +/- 0.13 cm, P = 0.015) and posterior wall (0.96 +/- 0.12 vs. 0.90 +/- 0.10 cm, P = 0.006) thickness. After adjustments for diabetes duration, sex, smoking, LDL cholesterol, and A1C values, all associations were sustained for daytime systolic blood pressure but not for office systolic blood pressure.
CONCLUSIONS: Type 2 diabetic patients with masked hypertension have higher UAER as well as enlargement of ventricular walls compared with the normotensive patients, according to ABPM. Therefore, ABPM is important to identify this high-risk group so as to be able to take interventionist measures.

Entities:  

Mesh:

Year:  2007        PMID: 17303786     DOI: 10.2337/dc06-2131

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  24 in total

1.  High-Sensitivity Cardiac Troponin T and Risk of Hypertension.

Authors:  John W McEvoy; Yuan Chen; Vijay Nambi; Christie M Ballantyne; A Richey Sharrett; Lawrence J Appel; Wendy S Post; Roger S Blumenthal; Kunihiro Matsushita; Elizabeth Selvin
Journal:  Circulation       Date:  2015-07-07       Impact factor: 29.690

Review 2.  Ambulatory blood pressure monitoring: from old concepts to novel insights.

Authors:  Mehmet Kanbay; Kultigin Turkmen; Tevfik Ecder; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-07-06       Impact factor: 2.370

3.  Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study.

Authors:  Paul E Drawz; Roland Brown; Luca De Nicola; Naohiko Fujii; Francis B Gabbai; Jennifer Gassman; Jiang He; Satoshi Iimuro; James Lash; Roberto Minutolo; Robert A Phillips; Kyle Rudser; Luis Ruilope; Susan Steigerwalt; Raymond R Townsend; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-05       Impact factor: 8.237

Review 4.  [Treatment of hypertension in diabetic patients].

Authors:  Jörg Slany
Journal:  Wien Med Wochenschr       Date:  2010-01

Review 5.  The complexity of masked hypertension: diagnostic and management challenges.

Authors:  Stanley S Franklin; Nathan D Wong
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

6.  Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes.

Authors:  M Wijkman; T Länne; J Engvall; T Lindström; C J Ostgren; F H Nystrom
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

7.  Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Authors:  E Ritz; G C Viberti; L M Ruilope; A J Rabelink; J L Izzo; S Katayama; S Ito; A Mimran; J Menne; L C Rump; A Januszewicz; H Haller
Journal:  Diabetologia       Date:  2009-10-30       Impact factor: 10.122

Review 8.  Ambulatory blood pressure and cardiovascular risk in chronic kidney disease.

Authors:  Paolo Palatini
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

Review 9.  White-coat hypertension should not be treated in subjects with diabetes.

Authors:  Michael Bursztyn; Iddo Z Ben-Dov
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation.

Authors:  Jorge Esteves; Carolina Maurente da Rosa; Caroline Kaercher Kramer; Luiz Eduardo Osowski; Stéfano Milano; Luís Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2009-10-05       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.